论文部分内容阅读
目的:观察耳穴贴压联合沙美特罗丙酸氟替卡松吸入剂治疗咳嗽变异性哮喘的临床疗效。方法:选取62例咳嗽变异性哮喘患者作为研究对象,按照随机数字表法分为观察组(n=32)和对照组(n=30),观察组患者采取耳穴贴压联合沙美特罗丙酸氟替卡松吸入剂治疗,对照组患者单纯采用沙美特罗丙酸氟替卡松吸入剂治疗,观察比较两组患者咳嗽积分、第1秒用力呼气容积(FEV1)、最大呼气流量(PEF)情况及临床疗效。结果:治疗4周后,两组患者的咳嗽积分、FEV1及PEF均较治疗前有明显改善,差异具有统计学意义(P<0.05);在治疗4周时,观察组患者的咳嗽积分、FEV1及PEF均改善优于对照组,差异具有统计学意义(P<0.05)。观察组患者治疗总有效率为90.6%,明显高于对照组为80.0%,差异具有统计学意义(P<0.05)。结论:耳穴贴压联合沙美特罗丙酸氟替卡松吸入剂可改善患者症状,提高肺功能,疗效确切,值得临床推广运用。
Objective: To observe the clinical efficacy of auricular point pressing combined with salmeterol fluticasone propionate in the treatment of cough variant asthma. Methods: Sixty-two patients with cough variant asthma were selected as study subjects and divided into observation group (n = 32) and control group (n = 30) according to random number table. Patients in observation group were treated with auricular point pressure combined with salmeterol Fluticasone inhalation therapy, the control group of patients treated with salmeterol fluticasone propionate inhalation alone, the observed two groups of patients cough score, forced expiratory volume 1 second (FEV1), maximum expiratory flow (PEF) and clinical efficacy . Results: After 4 weeks of treatment, the cough scores, FEV1 and PEF in both groups were significantly improved compared with those before treatment (P <0.05). At 4 weeks, the cough scores, FEV1 And PEF improved better than the control group, the difference was statistically significant (P <0.05). The total effective rate of observation group was 90.6%, which was significantly higher than that of control group (80.0%), the difference was statistically significant (P <0.05). Conclusion: Auricular point pressure combined with salmeterol fluticasone propionate inhalation can improve the symptoms of patients and improve lung function, the curative effect is exact, worthy of clinical application.